OLD Category: Oncology Fusions
June 3, 2015 / Int. J. Lab. Hematol.
Detection of chromosomal translocations in formalin-fixed paraffin-embedded (FFPE) leukemic specimens by digital expression profiling
May 22, 2015 / Cancer Immunology, Immunotherapy
Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer model
May 13, 2015 / Cancer Discovery
Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping
December 18, 2014 / Endocr Relat Cancer.
Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer
September 19, 2014 / Mod. Pathol.
Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma
August 31, 2014 / Nature Med.
Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer
August 7, 2014 / Nat. Commun.
Recurrent ”‹ESR1–”‹CCDC170 rearrangements in an aggressive subset of ”‹oestrogen receptor-positive breast cancers
February 3, 2014 / J Thorac Oncol.
HIP1-ALK, A Novel ALK Fusion Variant that Responds to Crizotinib
January 10, 2014 / J. Molecular Diagnostics
A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer
December 2, 2013 / Journal of Clinical Endocrinology & Metabolism
RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma
November 20, 2013 / Lung Cancer